Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and HTLV-II Infections

cetylpyridinium chloride anhydrous has been researched along with HTLV-II Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adediran, A; Ajibola, S; Akinbami, A; Dada, A; Dosunmu, A; Durojaiye, I; Odesanya, M; Okunoye, O; Oshinaike, O; Uche, E1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and HTLV-II Infections

ArticleYear
Seroprevalence of human T lymphotropic virus antibodies among healthy blood donors at a tertiary centre in Lagos, Nigeria.
    The Pan African medical journal, 2014, Volume: 17

    Topics: Adult; Blood Donors; Cross-Sectional Studies; Female; Health; HTLV-I Antibodies; HTLV-I Infections; HTLV-II Antibodies; HTLV-II Infections; Human T-lymphotropic virus 1; Human T-lymphotropic virus 2; Humans; Male; Middle Aged; Nigeria; Seroepidemiologic Studies; Tertiary Care Centers; Young Adult

2014